OBJECTIVES: We sought to evaluate the surgical outcomes of the repair of complete atrioventricular septal defects (cAVSDs) in our institution in the current era.
INTRODUCTION
Mortality after repair of complete atrioventricular septal defects (cAVSDs) in the first year of life has decreased significantly during the last decade [1] [2] [3] [4] . However, the reoperation rate remains as high as 10-15% [1, 4, 5] . Reoperation is most often required for left atrioventricular (AV) valve (LAVV) regurgitation (LAVVR), followed by left ventricular outflow tract obstruction (LVOTO) and residual ventricular septal defects (VSDs) [4, 6] . Furthermore, there is a trend towards early cAVSD repair, yet the best timing of surgery is not clearly determined [5, 7, 8] .
The impact of Down's syndrome also remains unclear [9] [10] [11] . However, Down's syndrome does not appear to be a risk factor for operative mortality and, in fact, has been associated with lower reoperation rates [9] [10] [11] .
In this study, we reviewed our results of cAVSD repair in the current era to determine the optimal timing of repair and risk factors for reoperation.
MATERIALS AND METHODS
The study was approved by the Human Research Ethics Committee of the Royal Children's Hospital. Patients with associated tetralogy of Fallot (TOF), double outlet right ventricle (DORV), ventricular hypoplasia and anatomical variants not compatible with biventricular repair were excluded. A total of 138 consecutive patients with cAVSD ( Fig. 1 ) underwent definitive repair from January 2000 to January 2011 at the Royal Children's Hospital. Major associated cardiovascular anomalies were right ventricular outflow tract obstruction (RVOTO, n = 5, 3.6%), LVOTO (n = 4, 2.9%), aortic coarctation (n = 3, 2.2%), multiple VSD (n = 9, 6.5%), single LV papillary muscle (n = 7, 5.1%), double orifice LAVV (n = 5, 3.6%), left atrial isomerism (n = 3, 2.2%) and dextrocardia (n = 1, 0.7%). Other vascular anomalies were persistent left superior vena cava to coronary sinus (n = 9, 6.5%) and azygos continuation of the inferior vena cava (n = 2, 1.4%). In addition, 68 (49.3%) patients had a patent ductus arteriosus, 26 (18.8%) had a patent foramen ovale and 58 (42.0%) had a secundum atrial septal defect (ASD) requiring repair during cAVSD repair.
Cardiac surgery prior to definitive repair
Nine children were operated on prior to definitive repair of the cAVSD [patent ductus arteriosus (PDA) ligation, n = 1 and pulmonary artery (PA) banding, n = 8, including 3, who underwent concomitant COA repair and PDA ligation]. One of the patients with concomitant coarctation of aorta (COA) repair also had a resection of LVOTO.
PA banding was performed in 8 patients prior to cAVSD repair. Mean age was 1.7 ± 1.6 months and mean weight was 3.2 ± 0.9 kg at the time of PA banding. The mean interval from PA banding to definitive repair was 17.8 ± 13.5 months. During this interval, the patients gained a mean weight of 5.7 ± 3.5 kg. Thus, definitive cAVSD repair was performed at a mean age of 19.7 ± 13.7 months and a mean weight of 9.0 ± 3.8 kg.
The indications for PA banding prior to definitive repair were multiple VSDs (n = 4), necrotizing enterocolitis (n = 2, both patients underwent intestinal resection and, subsequently, underwent successful complete repair) and low birth weight (n = 1). One child of Jehovah's Witness parents underwent PA banding upon the parents' request and later, complete repair, to avoid blood transfusion. A further 2 patients underwent PA banding at the time of definitive repair, because of multiple VSDs.
Surgical technique of definitive repair
All patients underwent biventricular repair. Surgical repair was performed by six surgeons over the 10-year period. Repair was performed via sternotomy with cardiopulmonary bypass (CPB), hypothermia and cardioplegia. Median age at definitive repair was 3.2 months (range 0.6 months-14.8 years).
The cAVSD was closed using a two-patch technique in 92.0% (127 of 138) of patients (Fig. 2) , one-patch technique in 2.2% (3 of 138) and in 5.8% (8 of 138) a small VSD was closed directly. In 1 patient, a small primum ASD was closed with a direct suture. The coaptation points of the bridging leaflets were marked, the width of the bridging leaflets was measured and a generous VSD patch was used to avoid LVOTO ( Fig. 2A-C) . A small split in the upper aspect of the patch was performed in the area of coaptation of the anterior and posterior bridging leaflets to ensure good coaptation of the leaflets ( Fig. 2D and E) . Following placement of the ASD patch, a suture was placed to secure the coaptation area of bridging leaflets ( Fig. 2F and G) . A LAVV was tested with instillation of normal saline and, if there was no leakage, the cleft was left open. Intraoperative transoesophageal echocardiogram was performed after coming off CPB in all patients. Echocardiogram demonstrated moderate-to-severe LAVVR in 4 of 54 patients (7.4%, 4 of 54) in whom the cleft was initially left open. In these 4 patients, surgeons elected to go back on CPB to close the cleft that resulted in trivial LAVVR in all 4 patients. The cleft in the LAVV was closed completely in 43.5% (60 of 138), partially in 20.3% (28 of 138) or was left open in 36.2% (50 of 138) of patients. An annuloplasty of the LAVV was performed in 2.2% (3 of 138) of patients, and commissuroplasty was performed in 11 patients (8.0%, 11 of 138; anterolateral in 8 patients, posterolateral in 2 and both in 1). Patients with previous PA banding had PA reconstruction during the definitive repair of cAVSD. A secundum ASD was closed in all patients.
Definitions
Operative death was defined as death occurring prior to hospital discharge or within 30 days of definitive repair. Late death was defined as death occurring after discharge and >30 days after definitive repair. Complete cleft closure was defined as direct closure of the entire cleft of the LAVV. Partial cleft closure was defined as any degree of incomplete closure of the cleft. Significant LAVVR was defined as moderate or greater regurgitation. Prolonged mechanical ventilation was defined as postoperative mechanical ventilation longer than 72 h. Pneumonia was defined as pulmonary infiltrates on chest X-ray in association with 3 of the 
Data collection and statistical analysis
Data were collected retrospectively. The degree of LAVVR was recorded in grades of severity from absent or trivial to severe. Statistical analysis was performed using the SPSS Statistics version 17.0 (SPSS, Inc., Chicago, IL, USA). Continuous variables were expressed as mean ± standard deviation or median and range for highly skewed variables. Categorical variables were expressed as numbers of cases and percentages. The effect of age at definitive repair on outcomes was not expected to be linear. Therefore, for analysis, patients were divided into two groups, ≤6 and >6 months at repair. The choice of 6-month cut-off was determined using a fractional polynomial Cox regression model for hazard as a function of age at repair, where 6 months corresponded to a predicted hazard ratio of one (Fig. 3) , with predicted hazard being less than one for ages <6 months and greater than one for ages >6 months at repair.
The ≤6-month group was also further divided into ≤3 and >3 months age at repair, which corresponded to a 50 : 50 split of this subgroup. Differences in categorical variables between age groups, patients with and without cleft closure and those with and without Down's syndrome were assessed using the χ 2 -test or Fisher's exact test. Differences in continuous variables were assessed using the t-test or by non-parametric testing using the Mann-Whitney U-test for skewed outcomes. Actuarial survival was calculated using the Kaplan-Meier method. Cox proportional hazards regression analysis was used to identify the predictors for reoperation. Variables with a P-value of ≤0.05 on univariable analysis were subsequently included in a multivariable analysis.
RESULTS

Early outcomes
The characteristics of 138 patients who underwent definitive repair of cAVSD are presented in Table 1 . Operative morality was 1.4% (2 of 138). One patient died in 2000 of ventricular dysfunction 16 days after definitive repair. The other patient died in 2001 on the day of definitive repair from hyperkalaemia secondary to acute renal failure.
Postoperative complications occurred in 53% (73 of 138) of patients prior to discharge and included pleural effusion (n = 17, 12%, 7 required drainage), pericardial effusion (n = 5, 3.6%, all required drainage), renal insufficiency (n = 13, 9.4%), respiratory (n = 10, 7%) and urinary tract (n = 11, 8%) infection. Prolonged mechanical ventilation was required in 24.6% (34 of 138) of patients. One patient had a cardiac arrest on the day of surgery, but was successfully resuscitated. Documented arrhythmias included third-degree AV block (n = 9, 6.5%) and junctional ectopic tachycardia (n = 15, 11%). Only 1 patient required permanent pacemaker (PPM) insertion for third-degree AV block during their hospital admission, and the rest regained normal sinus rhythm.
At discharge from the hospital, 16% (22 of 138) of patients had moderate or greater (significant) LAVVR. Of the patients operated on at the age of <6 months: 13.3% (15 of 113) had significant LAVVR preoperatively and 17.7% (20 of 113) had significant LAVVR postoperatively. Of patients operated on at >6 months, 16% (4 of 25) had significant LAVVR preoperatively and 8.0% (2 of 25) had significant LAVVR postoperatively. Children who required cleft closure (partial or complete) were more likely to have moderate or greater LAVVR at discharge compared with those who had the cleft left open (P = 0.016, 21.6 vs 6.0%). In addition, 7.2% (10 of 138) of patients had moderate right AVVR. There were no patients with significant LAVV stenosis at discharge.
Late outcomes
The current follow-up was available for 96% (132 of 136) of patients during the 3-year period from July 2008 to July 2011 and 88% (120 of 136) of patients during the 2-year period from July 2009 to July 2011. The mean length of follow-up was 4.7 ± 3.2 years (range 1 month-11.4 years). Two patients from overseas had no follow-up available. Of the Australian patients, 1 did not have current follow-up and 2 had no follow-up available.
Late mortality was 4.4% (6 of 136) and occurred at a median period of 22 months (range 1.5 months-5.3 years) after cAVSD repair. Two of these deaths were due to non-cardiac causes. One patient died 3 months after cAVSD repair of pneumonia. An echocardiogram done 1 month prior to death demonstrated good cardiac function with mild LAVVR. The patient had multiple choking episodes and developed pneumonia, respiratory failure sepsis and died. The other patient died 5.2 years after cAVSD repair from sepsis secondary to acute lymphoblastic leukaemia. One patient had a reoperation for LAVVR 7 days after definitive repair, was discharged with mild LAVVR, but severe PA hypertension and then died 40 days after the reoperation from ventricular dysfunction. Another patient was discharged and died 49 days after definitive repair from ventricular dysfunction. A further 2 deaths occurred 2.5 years after cAVSD repair. Both patients had previously been well, had normal cardiac function and trival LAVVR and died following acute respiratory infection. Overall survival was 96.3% (95% CI 93.1-99.5%) at 1 year, 94.1% (95% CI 89.7-98.5%) at 3 and 5 years as well as 92.2% (95% CI 86.4-98.0%) at 8 years (Fig. 4) .
Annuloplasty was performed in 3 patients. All had deficient lateral leaflet of the LAVV. The cleft was closed completely in all 3 patients. The first patient was operated on at the age of 18 months and had 1 commissuroplasty stitch to approximate lateral and inferior bridging leaflets and posterior annuloplasty with 4-0 PDS suture. This international patient had only 2 months of follow-up. The second patient was operated on at the age of 7 months and had a strip of 0.6 mm GoreTex form the anterior portion of the ASD patch, around the LAVV annulus, ending at the site of the coronary sinus. The third patient was operated on at the age of 3 months and posterior annuloplasty was performed with three mattress sutures of 5-0 Ticron. The latter 2 patients are asymptomatic and without LAVV stenosis or insufficiency at 6 and 8 years after surgery, respectively. Commissuroplasty was performed in 11 patients (8.0%, 11 of 138; anterolateral in 8 patients, posterolateral in 2 and both in 1). Immediately postoperatively, 36.5% (4 of 11) had moderate or greater LAVVR. Reoperation was required in 27.3% (3 of 11) of patients who had commissuroplasty: 2 for LAVVR during the same admission and 1 for late LVOTO. Only 18.2% (2 of 11) of patients .1%) at 8 years. In addition, there was 1 (0.8%, 1 of 132) patient with LVOTO and 2 (1.5%, 2 of 132) patients with a complete heart block requiring PPM insertion after discharge. One patient had atrial PPM inserted 41 months after cAVSD repair for sick sinus node syndrome with bradycardia. The other patient had PPM inserted 2 months after cAVSD repair, when he developed an asymptomatic complete heart block. There were no patients with significant LAVV stenosis or right AVVR. Nineteen (17%, 19 of 112) patients with trivial-to-mild LAVVR at discharge developed moderate or greater LAVVR at the most recent followup or required a reoperation for LAVVR (2 of 19).
Postoperatively, 16% (22 of 138) of patients had moderate or greater LAVVR; 9 of them had reoperations for LAVVR, 4 had persisting moderate or greater LAVVR at latest follow-up (at 47, 97, 113 and 52 months) and in 9 patients the LAVVR became less than moderate (at the mean follow-up of 6.2 years, median 6.5 years, range 11 months-10.8 years).
Reoperation was required in 13% (18 of 138) of patients at a median period of 0.3 months (range 1 day-4.5 years) after definitive surgical repair. Three (2.2%, 3 of 138) patients required a second reoperation at a median period of 3.1 years (range 2.3-3.3 years) after definitive surgical correction. Two of these were for further LAVV repair and one for LVOTO. The most common reasons for reoperation were LAVVR (9.4%, 13 of 138), followed by residual VSD (2.2%, 3 of 138), muscular VSDs (2.2%, 3 of 138), LVOTO (2.2%, 3 of 138), RVOTO (0.7%, 1 of 138) and residual ASD (0.7%, 1 of 138). Freedom from reoperation was 90.2% (95% CI 85.0-95.4%) at 1 year, 87.1% (95% CI 81.1-93.1%) at 3 years, 84.3% (95% CI 77.1-91.6%) at 5 and 8 years (Fig. 5 ).
There were 15 reoperations on the LAVV in 13 patients. Prior to reoperation (i.e. at the definitive repair), the cleft was closed completely in 5 patients, partially in 4 and left open in 4. At reoperation, of 5 patients with complete cleft closure, 1 had endocarditis and 4 had cleft dehiscence, including one with residual VSD; of 4 patients with partial cleft closure, cleft was dehisced in all, including 1 with dehiscence of the superior bridging leaflet from
Of 50 patients who did not have cleft closure during the initial operation, 6% (3 of 50) had moderate or greater LAVVR postoperatively and 1 of them was reoperated, and 14% (7 of 50) with less than moderate LAVVR postoperatively developed moderate or greater LAVVR at follow-up (mean 4.2 years, median 3.7 years, range 9 months-9.4 years). Further, 6% (3 of 50) of patients who had less than moderate LAVVR postoperatively developed moderate-to-severe LAVVR and underwent reoperation with cleft closure, one of them developed LVOTO 2 years after reoperation for cleft closure due to a discrete subaortic membrane and had to be reoperated to resect the LVOTO. Thus, a total of 4 patients (8%, 4 of 50) required subsequent cleft closure. One additional patient (2%, 1 of 50) developed LVOTO due to discrete subaortic membrane 2 years after definitive repair and underwent LVOTO resection. Of 4 patients in whom the cleft was initially left opened, all had the cleft closed at reoperation, including 1 patient with dehisced superior bridging leaflet from VSD patch. In patients with endocarditis, the damaged portion of the valve was resected and reconstructed with pericardial patch, in others, cleft closure and re-suturing of the dehisced VSD patch was done. Thus, leaving the cleft open was not a risk factor for reoperation. In fact, cleft dehiscence was just as common after complete or partial closure of the cleft at initial operation.
Univariable analysis demonstrated that children aged >6 months at the time of definitive repair, those who had moderate or greater LAVVR at discharge following definitive repair and those with PA banding, were at increased risk for reoperation. Down's syndrome was protective for reoperation (Table 2) . However, multivariable analysis demonstrated that only age at definitive repair of >6 months (P = 0.001; HR 6.85; 95% CI 2.30-20.44%) and moderate or greater LAVVR at discharge following definitive repair (P<0.001; HR 10.85; 95% CI 3.75-31.40%) were independent risk factors for reoperation (Table 2) . Cleft closure and severity of preoperative LAVVR were not independent risk factors for reoperation.
Analysis by age at repair
For patients divided into those aged ≤6 and >6 months at definitive repair, there was no evidence of a difference in CPB time, crossclamp time, annuloplasty or commissuroplasty rate (Table 3) . Patients operated on at >6 months of age were more likely to have the cleft closed (P = 0.005; 88 vs 58%). Children operated on at ≤6 months of age stayed in the intensive care unit (ICU; P = 0.019; 2.7 vs 1.4 days) and the hospital (P = 0.02, 8 vs 5 days) longer and required longer mechanical ventilation (P = 0.001, 1.7 vs 0.9 days). However, age at surgery was unrelated to complication rates prior to discharge, and there was no evidence of a relationship with overall mortality, due in part to the small number of deaths in the data. Children who were >6 months at the time of definitive repair were reoperated more frequently (univariable: P = 0.02; HR 3.14; 95% CI 1.22-8.10 and multivariable: P = 0.001; HR 6.85; 95% CI 2.30-20.44) (Fig. 5) . There was no difference in moderate or greater LAVVR at latest follow-up.
The patients were further subdivided into those aged 0-3 and 3-6 months at the time of definitive repair. There was no difference in ICU stay, duration of mechanical ventilation or postoperative complications between children <3 and 3-6 months of age at definitive repair. The mean period of follow-up for children aged <3 months was 56.6 months and similar to the mean period of follow-up for children aged >3 months, that was 58.5 months. However, children aged <3 months stayed longer in the hospital postoperatively compared with both children aged 3-6 months (P = 0.004, 9.0 vs 7.0 days) and those aged >6 months (P = 0.004, median 9 vs 5 days). There was no difference in postoperative hospital stay between children aged 3-6 months and those aged >6 months at repair. At the latest follow-up, there was no difference in reoperation rates between children aged 3-6 months and those aged <3 months at definitive repair. Children aged <3 months had a higher degree of LAVVR compared with those aged 3-6 months (P = 0.02, 22.8 vs 12.5%) at the time of discharge.
The LAVV cleft was left open more often in patients aged <3 months (P = 0.003; 46 vs 12%) and those aged 3-6 months (P = 0.02; 38 vs 12%) at definitive repair compared with those aged >6 months (12%). There was no difference in the rate of cleft closure between children aged ≤3 and 3-6 months. At the most recent follow-up, there was no difference in reoperation rates or severity of LAVVR between children aged ≤3 and 3-6 months. Definitive repair at ≤3 months of age was not a risk factor for overall mortality.
Analysis of the impact of Down's syndrome
Down's syndrome was present in 75% (104 of 138) of patients. Major associated cardiovascular anomalies were more common in children without Down's syndrome (44.1%, 15 of 34) than those with Down's syndrome (12.5%, 13 of 104) (P < 0.001). There was no difference in age at definitive repair, gender, weight and body surface area at repair between patients with and without Down's syndrome. There was no difference in rates of cleft closure, commissuroplasty or annuloplasty between the two groups. Patients with normal karyotype had significantly longer bypass (P = 0.04; 173 vs 149 min) and cross-clamp (P = 0.03; 127 vs 111 min) times.
Moreover, patients with normal karyotype stayed longer in ICU (P = 0.03; median 4 vs 2 days) and in the hospital postoperatively (P = 0.001; median 11 vs 7 days). There was no difference in postoperative complication rates prior to discharge or overall mortality. There was a tendency towards higher reoperation rates in patients with normal karyotype on univariable analysis (P = 0.04; HR 2.61; 95% CI 1.03-6.63), but it was not confirmed on multivariable analysis. Down's syndrome was unrelated to the severity of LAVVR at latest follow-up.
DISCUSSION
This study focused on the outcomes of children undergoing definitive surgical correction of a simple cAVSD in the current era. We have previously reported the outcomes of patients with associated cardiac TOF or DORV and excluded them from the current study [12] . Compared with an earlier report [11] from our unit, the operative mortality decreased from 3.0 to 1.4%. However, late mortality and reoperation rate remained unchanged [11] . During the decade of our study, we put a strong emphasis on achieving a secure coaptation of the bridging leaflets (Fig. 2) . If good coaptation and competency of the LAVV were achieved, the cleft was left open. We aimed to achieve LAVV competency at initial repair by good coaptation of the leaflets and without cleft closure, rather than to close the cleft in order to ensure the competence. If competency of the LAVV could not be achieved and cleft closure was required to achieve such competency, the incidence of moderate or greater LAVVR at discharge was higher. Although the latter was a risk factor for reoperation, the status of the cleft, regardless of whether it was left open or closed, was not an independent factor for reoperation.
We feel that it is important to emphasize that children with cleft closure were more likely to have a higher degree of LAVVR at the time of discharge from the hospital in our series, because the patients in whom the competence could not be achieved initially without cleft closure had the cleft closed to achieve competence. It appears that if 'the cleft closure was required to achieve the competence of the LAVV', the patients were more likely to develop moderate or greater LAVVR postoperatively. We never divided the bridging leaflets to apply a single-patch technique. The detrimental effect of bridging leaflet division has previously been described [13] . In rare instances when VSD was small, a single patch was used to close the atrial septal component, while the VSD was closed with interrupted stitches. Of interest, of 8 patients, in whom VSD was closed directly, 3 were <6 months and 1 was 6.5 months of age. Excluding these 8 patients from analysis did not appreciably change the results.
Early outcomes
Prior to 2000, reported operative mortality was 10% [1, 8] . Early mortality has improved significantly over the last decade [4, 5, 7, 9, 10] . The operative mortality was 1.4% (2 of 138) in the current study and similar to those reported by others [5-7, 9, 10] . Multivariable analysis to identify risk factors for operative mortality was not feasible as there were only 2 in-hospital deaths.
Up to 80% of children with cAVSD also have Down's syndrome [4, 9, 10] . Recent studies have suggested that patients with Down's syndrome do not have increased mortality [9, 10] and, in fact, have fewer reoperations [9] . Neither Down's syndrome nor age at definitive repair was a risk factor for overall mortality on univariable analysis. This is consistent with the current literature [5, 7, 10] .
An early postoperative complication rate of 41-50% has been reported [10] . Arrhythmia in the postoperative period is a common problem in cAVSD repair [10, 14] . Prifti et al. [14] reported arrhythmia in 15% of patients postoperatively, but only 2% required a PPM. Indeed, arrhythmia was the most frequent complication in this study, namely. However, PPM was required only in 2 patients prior to discharge.
Late outcomes
There were 4 cardiac and 2 non-cardiac late deaths. Thus, late mortality was 4.4% (6 of 136). Actuarial survival at 8 years was 92.2% (95% CI 86.4-98.0%) and comparable with other studies [3, 15] .
Despite improvements in mortality in the last two decades, the reoperation rate remains high following definitive cAVSD repair [1, [4] [5] [6] [7] . Reoperation is most frequently due to left AVVR, followed by residual VSD and LVOTO [4, 6, 13, 15] . The reoperation rate in our study was 13% (18 of 138), with the majority of reoperations (72%, 13 of 18) for LAVV repair. Eight (5.8%, 8 of 138 or 61%, 8 of 13) patients had cleft dehiscence. This was similar to the recent study of Bakhtiary et al. [2] that demonstrated a reoperation rate for LAVVR of 6% (6 of 100) with dehiscence in 4 (66%, 4 of 6) patients. Three of our patients required a second reoperation. Two required additional repair of the LAVV and one required relief of LVOTO. The incidence of reoperation for LVOTO in our study was 2.2% (3 of 138) and similar to that reported currently from 2 to 5.6% [3] [4] [5] . Freedom from reoperation was 84.3% (95% CI 77.1-91.6%) at 8 years and comparable with that reported by others [8, 9] .
Multivariable analysis identified older age at definitive repair (>6 months) as a risk factor for reoperation. Currently, cAVSD is repaired during the first year of life in most institutions [1, 2, 4, 8, 10] . Although we have found that repair before the age of 6 months was associated with lower rates of reoperation, younger age at operation was also associated with longer ICU stay, mechanical ventilation and postoperative hospital stay. Interestingly, younger age was not associated with higher complication rates during hospital stay or overall mortality.
Recent studies advocated repair within the first 3 months of life on the basis that operating before 3 months of age did not increase operative mortality [7, 8] . In our study, repair before the age of 3 months did not appear to offer any advantage over operating between 3 and 6 months of age. There was no difference in overall mortality (7%, 4 of 57 vs 5%, 3 of 56) or reoperation rates (12%, 7 of 56 vs 7%, 4 of 56) between 3 and 3-6 months of age, respectively. Children operated on at <3 months of age had similar length of ICU stay and mechanical ventilation compared with those operated on at 3-6 months of age, but spent a longer time in hospital postoperatively (median 9 vs 7 days). In addition, children aged ≤3 months at repair had higher incidence of moderate or greater LAVVR at discharge compared with those aged 3-6 months. This is despite the fact that the two groups had similar rates of reoperation and cleft closure and likely reflects the difficulties in manipulating delicate valvular tissue in the youngest of patients. The article published from our institution in 1990 [11] described frequent closure of the cleft. At the present time, we aimed to achieve competence of the LAVV prior to cleft closure, by ensuring a good area of coaptation of the bridging leaflets. The technique described here illustrates the key points to achieve a good coaptation. We believe that, if such coaptation is achieved from the beginning, there is no need to close the cleft. If the LAVV is incompetent to the point that we have to close the cleft to achieve the competency of the LAVV, the end results may not be as good. Thus, our current strategy is to achieve the competency of the LAVV without cleft closure, with the technique described.
PA banding was not an independent risk factor for reoperation. It was rarely performed preoperatively and only in those patients who were deemed to have a higher risk for definitive cAVSD repair due to low birth weight, multiple VSDs, necrotizing enterocolitis or refusal of transfusion.
Moderate or greater LAVVR in the early postoperative period was a risk factor for reoperation on multivariable analysis. This correlation has been previously observed by others [3, 6] . Moderate or greater preoperative LAVVR, lack of cleft closure and LAVV anomalies, including single papillary muscle and double orifice LAVV, have also all been associated with higher rates of reoperation elsewhere [1, 6, 14] , but not in our patients.
The cleft was left open more frequently in children <6 months of age compared with those >6 months of age. It appeared that it was more difficult to achieve a good coaptation without cleft closure in children >6 months of age. The reason for this is not clear, but could be due to a cumulative damage of the leaflets that occurred over time. This damage might, in part, explain why age at repair >6 months was an independent risk factor for reoperation.
Similar to others [9] [10] [11] , we observed a trend towards lower reoperation rates for patients with Down's syndrome compared to those without it. In our study, children with Down's syndrome had shorter aortic cross-clamp time and CPB time. This is likely related to the fact that children with Down's syndrome, in this study, also had fewer associated major cardiovascular anomalies.
Limitations
The study was limited by its retrospective nature. In addition, a number of patients did not have the Rastelli type of their cAVSD described. Therefore, a more definitive comment on the impact of Rastelli type on outcomes could not be made. Furthermore, we report our results with a policy of trying to achieve a good coaptation of the LAVV without cleft closure. The design of the study does not permit comparisons of 'cleft closure' vs 'non-cleft closure'. There would be bias, as we closed the cleft when the competence of the valve could not be achieved by good coaptation.
CONCLUSION
Repair of cAVSD carries low mortality, but a moderate reoperation rate. An optimal time for repair of the cAVSD appears to be between 3 and 6 months of age. Patients operated on before the age of 6 months had lower reoperation rates, but a longer median hospital stay. Repair prior to 3 months of age and the need for cleft closure were associated with a higher degree of LAVVR at discharge. Greater LAVVR at discharge is a risk factor for reoperation regardless of age at the time of initial repair. In the current era, Down's syndrome is not a risk factor for reoperation.
